The final stages of prostate cancer occur when the disease has spread beyond the prostate to distant parts of the body, most commonly the bones. At this point, the cancer is classified as Stage IV, and the five-year relative survival rate drops to about 38%. Understanding what happens during this phase, from how the cancer spreads to what symptoms develop and how they’re managed, can help patients and families prepare for what lies ahead.
How Stage IV Is Classified
Stage IV prostate cancer is divided into two substages. Stage IVA means cancer has spread to nearby lymph nodes in the pelvis but hasn’t reached distant organs. Stage IVB means the cancer has metastasized to distant sites: bones, lymph nodes far from the prostate, or organs like the liver and lungs. Stage IVB is what most people mean when they refer to the “final stage” of prostate cancer.
Among patients with metastatic prostate cancer, bone is by far the most common destination, showing up in 84% of cases. Distant lymph nodes are involved in about 11% of cases, the liver in about 10%, and the chest (lungs or other thoracic structures) in roughly 9%. Nearly one in five patients has cancer in more than one of these sites. When the cancer reaches the liver or lungs, the odds of having multiple metastatic sites climb to around 76%, reflecting a more aggressive pattern of spread.
Castration-Resistant Disease
Prostate cancer depends heavily on testosterone to grow, which is why one of the primary treatments is hormone therapy that lowers testosterone to very low levels. Over time, though, cancer cells can develop workarounds. They may mutate their hormone receptors or amplify certain genes so they can keep growing even without testosterone. When this happens and the cancer continues to progress despite hormone suppression, it’s called castration-resistant prostate cancer.
The hallmark of this transition is a rising PSA level even though testosterone remains suppressed. PSA doubling time, which tracks how quickly PSA levels are climbing, becomes an important marker. A rapid doubling time signals aggressive disease progression. Metastatic castration-resistant prostate cancer (mCRPC) is widely considered the final clinical phase of the disease and carries the highest mortality risk. At this point, treatment shifts toward slowing progression and managing symptoms rather than achieving remission.
What Bone Metastasis Feels Like
Because bone involvement is so common, many of the symptoms in the final stages trace directly back to what the cancer is doing to the skeleton. The major complications include persistent bone pain, pathological fractures (bones breaking from normal activity because tumors have weakened them), and spinal cord compression.
Spinal cord compression happens when cancer in the spine presses against the spinal cord or surrounding nerves. It causes severe back pain, weakness in the legs, numbness or tingling, and difficulty walking. In some cases it affects bladder and bowel control. This is a medical emergency because delays in treatment can lead to permanent paralysis. Bones are most at risk of fracturing when a tumor creates a visible weak spot larger than about 25 millimeters, or when more than half the bone’s outer layer is compromised.
Radiation therapy aimed at specific bone lesions provides pain relief in up to 80% of patients. For people with widespread bone pain across many sites, injectable radiopharmaceuticals (compounds that deliver targeted radiation to bone tumors) are also effective, achieving some degree of pain relief in roughly 80% of patients with diffuse bone metastases.
Metabolic Complications
High blood calcium, known as hypercalcemia, affects an estimated 30% of people with cancer and becomes more common in advanced stages. It happens when cancer in the bones releases excess calcium into the bloodstream, or when tumors produce proteins that disrupt the body’s normal calcium regulation.
Mild cases cause loss of appetite, constipation, and fatigue. As calcium levels climb higher, symptoms escalate to nausea, vomiting, weight loss, excessive thirst, and frequent urination. The neurological effects can be significant: anxiety, depression, confusion, muscle weakness, and lethargy. In severe cases, hypercalcemia can cause seizures, kidney failure, dangerous heart rhythm changes, or coma. It’s one of the reasons that patients in the final stages of prostate cancer can seem to decline suddenly rather than gradually.
Symptoms in the Final Weeks and Days
As the body begins to shut down in the terminal phase, a distinct pattern of changes emerges that’s common across many types of advanced cancer. Profound fatigue is one of the most universal symptoms in the last days of life. Patients sleep for longer and longer periods and become harder to wake.
Breathing patterns change noticeably. Breathing may become irregular, with cycles of very shallow breaths, brief pauses where breathing stops entirely, and occasional deep or rapid breaths. Shortness of breath is common and can be distressing for both the patient and those around them.
Delirium is also common during the final days. Some people become agitated or restless, a state sometimes called terminal restlessness. Others experience hallucinations, seeing or hearing things that aren’t there. Confusion may come and go, with moments of clarity mixed with periods of disorientation. Constipation, difficulty swallowing, and a near-complete loss of interest in food and water are typical as well. These changes don’t all happen at once; they tend to develop gradually over the final one to two weeks.
Hospice and End-of-Life Care
Hospice care becomes an option when a physician and hospice medical director agree that a patient’s expected prognosis is six months or less. The goal shifts entirely to comfort: managing pain, controlling symptoms like nausea and breathlessness, and supporting the patient’s quality of life and emotional wellbeing.
Timing matters. Some patients are referred to hospice very late, with fewer than seven days before death, which limits the benefit they and their families can receive. Patients with multiple other health conditions alongside their cancer are actually less likely to use hospice, possibly because the complexity of their care keeps them in hospital settings longer. Early hospice enrollment gives families more time to receive support, coordinate care at home, and focus on comfort rather than crisis management.
What Survival Numbers Mean in Context
The five-year relative survival rate for distant-stage prostate cancer is 37.9%, based on data from the National Cancer Institute’s SEER program covering diagnoses from 2015 through 2021. That number represents an average across all patients diagnosed at the distant stage, including those who respond well to treatment for years and those with rapidly progressive disease. Individual prognosis depends heavily on where the cancer has spread, how it responds to treatment, the patient’s overall health, and whether the cancer has become castration-resistant. Patients with bone-only metastases, for instance, generally fare better than those whose cancer has reached the liver or brain.